4//SEC Filing
Holtzman Douglas 4
Accession 0001209191-22-009513
CIK 0001786255other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:04 PM ET
Size
14.6 KB
Accession
0001209191-22-009513
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Holtzman Douglas
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-02-10+19,485→ 303,633 total - Gift
Common Stock
2021-12-31−10,000→ 42,440 total(indirect: By Stanley Holtzman) - Award
Stock Option (Right to Buy)
2022-02-10+81,950→ 81,950 totalExercise: $17.55Exp: 2032-02-09→ Common Stock (81,950 underlying)
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") which will vest as to 25% of the total number of RSUs granted on each of the first four anniversaries of February 10, 2022, subject to the reporting persons continued service through the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer and the RSUs have no expiration date.
- [F2]Includes 1,666 shares acquired under the Issuer's employee stock purchase plan on November 30, 2021.
- [F3]Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.
- [F4]25% of the shares subject to the option will vest on February 10, 2023, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874371
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 7:04 PM ET
- Size
- 14.6 KB